Clinical - Others
Liu H, Hu S. Acute leukemic variant of blastic plasmacytoid dendritic cell neoplasm at initial presentation. Blood. Apr 23;135(17):1506. doi: 10.1182/blood.2020005039. PMID: 32324873
Liu H, Xiang C, Wu M, Hu S. Follicular dendritic cell sarcoma with co-expression of CD4 and CD30 mimics anaplastic large cell lymphoma. Front Oncol. 2020 May 29;10:876. doi: 10.3389/fonc.2020.00876. eCollection 2020.
Yang Y, Tang Z, Huang Y, Hu Q, Wang S, Ji J, Du Y, Yang C, Chen M, Hu S, Han B. Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study. Blood Cancer J. 2023 May 10;13(1):74. doi: 10.1038/s41408-023-00845-3. PMID: 37160872
Toruner GA, Tang Z, Tang G, Medeiros LJ, Hu S. Low ALK FISH positive metastatic non-small cell lung cancer (NSCLC) patients have shorter progression-free survival after treatment with ALK inhibitors. Cancer Genet. 2020 Feb;241:57-60. doi: 10.1016/j.cancergen.2019.12.003. PMID: 31870845
Hu S, Bueso-Ramos CE, Verstovsek S, Miranda RN, Yin CC, McDonnell T, Medeiros LJ, Lin P. Metastatic splenic angiosarcoma presenting with thrombocytopenia and bone marrow fibrosis mimicking idiopathic thrombocytopenic purpura and primary myelofibrosis: a diagnostic challenge. Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):629-33. doi: 10.1016/j.clml.2012.12.013. PMID: 23800601
Hu S, Mrak RE, Goldblatt PJ. Tripartite components of a hepatocellular carcinoma with distinct immunohistochemical and metastatic features. Conn Med. 2010 Feb;74(2):79-83. PMID: 20218042
Oo, TH, Hu S. Copper deficiency related bone marrow changes secondary to long-term total parenteral nutrition. Clin Case Rep. 2017 Feb;5(2):195-196. doi: 10.1002/ccr3.789. PMID: 28174650
Jain P, Hu S, Jabbour E, Takahashi K, Pemmaraju N, O’Brien S, Mulanovich VE, Estrov Z. Disseminated histoplasmosis as pseudo Richter’s transformation in a patient with chronic lymphocytic leukemia. Am J Hematol. 2015 Aug;90(8):752-3. doi: 10.1002/ajh.24029. PMID: 25850565
Baraban EG, Hu S, Hui P, Podoltsev N, Cooper D, Xu ML. Tissue based chimerism analysis enhances detection of donor derived neoplasm in allogeneic stem cell transplant patients. Bone Marrow Transplant. 2017 Apr;52(4):634-637. doi: 10.1038/bmt.2016.332. PMID: 27991892
Jain P, Milgrom SA, Patel KP, Nastoupil L, Fayad L, Wang M, Pinnix CC, Dabaja BS, Smith GL, Yu J, Hu S, Bueso-Ramos CE, Kanagal-Shamanna R, Medeiros LJ, Oki Y, Fowler N. Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma. Br J Haematol. 2017 Aug;178(3):403-412. doi: 10.1111/bjh.14672. PMID: 28382648
Fang L, Chen H, Tang Z, Kalhor N, Liu CH, Yao H, Hu S, Lin P, Zhao J, Luthra R, Singh RR, Routbort MJ, Hong D, Medeiros LJ, Lu X. MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer. Oncotarget 2018 Feb 7;9(16):12959-12970. doi: 10.18632/oncotarget.24430. PMID: 29560123
Boddu PC, Wang S, Pemmaraju N, Tang Z, Hu S, Li S, Xu J, Medeiros LJ, Tang G. 8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms. Leuk Res. 2018 Mar;66:73-78. doi: 10.1016/j.leukres.2018.01.013. PMID: 29407586
Chamoun K, Loghavi S, Pemmaraju N, Konopleva M, Kroll M, Nguyen-Cao M, Hornbaker M, DiNardo CD, Kadia T, Jorgensen J, Andreeff M, Hu S, Benton CB. Early detection of transformation to BPDCN in a patient with MDS. Exp Hematol Oncol 2018 Oct 6;7:26. doi: 10.1186/s40164-018-0117-6. eCollection 2018. PMID: 30323983
Tang Z, Li Y, Wang W, Yin CC, Tang G, Aung PP, Hu S, Lu X, Toruner GA, Medeiros LJ, Khoury JD. Genomic alterations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events. Leuk Res 2018 Oct; 73: 86-94. doi: 10.1016/j.leukres.2018.09.006. PMID: 30248580
Li K, Xu W, Lu K, Wen Y, Xin T, Shen Y, Lv X, Hu S, Jin R, Wu X. CSFR1 inhibition disrupts the dialogue between leukemia cells and macrophages and delays leukemia progression. J Cell Mol Med 2020 Oct 10;24(22):13115-28. doi: 10.1111/jcmm.15916. PMID: 33037771.
Fang H, Chuang HH, Strati P, Hu S, Shuai W, Medeiros LJ, Wang W. Post chemotherapy histiocyte-rich pseudotumor mimicking residual lymphoma: a report of 11 cases correlating clinicopathologic and radiologic findings. Am J Surg Pathol. 2020 Aug 5. doi: 10.1097/PAS.0000000000001547. PMID: 32769427. Online ahead of print.
Yin W, Cheng J, Tang Z, Toruner G, Hu S, Guo M, Robinson M, Medeiros LJ, Tang G. MET amplification (MET/CEP7 ratio >1.8) is an independent poor prognostic marker in patients with treatment-naïve non-small cell cancer. Clin Lung Cancer. 2021 Jul;22(4):e512-e518. doi: 10.1016/j.cllc.2020.11.002. PMID: 33288441.
Yin W, Liu W, Guo M, Tang Z, Toruner G, Robinson M, Cheng J, Hu S, Medeiros LJ, Tang G. Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients’ outcome. Exp Mol Pathol. 2021 Feb;118:104572. doi: 10.1016/j.yexmp.2020.104572. PMID: 33189723.
Ricks ET, Hu S, Hu Z. Cytokeratin-positive follicular dendritic cell sarcoma: a mimic of carcinoma. eJHaema. 2022 Feb;3(1):254-255. http://dx.doi.org/10.1002/jha2.344. PMID: 35846219.
Liu H, Xiang C, Wu M, Hu S. Follicular dendritic cell sarcoma with co-expression of CD4 and CD30 mimics anaplastic large cell lymphoma. Front Oncol. 2020 May 29;10:876. doi: 10.3389/fonc.2020.00876. eCollection 2020.
Yang Y, Tang Z, Huang Y, Hu Q, Wang S, Ji J, Du Y, Yang C, Chen M, Hu S, Han B. Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study. Blood Cancer J. 2023 May 10;13(1):74. doi: 10.1038/s41408-023-00845-3. PMID: 37160872
Toruner GA, Tang Z, Tang G, Medeiros LJ, Hu S. Low ALK FISH positive metastatic non-small cell lung cancer (NSCLC) patients have shorter progression-free survival after treatment with ALK inhibitors. Cancer Genet. 2020 Feb;241:57-60. doi: 10.1016/j.cancergen.2019.12.003. PMID: 31870845
Hu S, Bueso-Ramos CE, Verstovsek S, Miranda RN, Yin CC, McDonnell T, Medeiros LJ, Lin P. Metastatic splenic angiosarcoma presenting with thrombocytopenia and bone marrow fibrosis mimicking idiopathic thrombocytopenic purpura and primary myelofibrosis: a diagnostic challenge. Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):629-33. doi: 10.1016/j.clml.2012.12.013. PMID: 23800601
Hu S, Mrak RE, Goldblatt PJ. Tripartite components of a hepatocellular carcinoma with distinct immunohistochemical and metastatic features. Conn Med. 2010 Feb;74(2):79-83. PMID: 20218042
Oo, TH, Hu S. Copper deficiency related bone marrow changes secondary to long-term total parenteral nutrition. Clin Case Rep. 2017 Feb;5(2):195-196. doi: 10.1002/ccr3.789. PMID: 28174650
Jain P, Hu S, Jabbour E, Takahashi K, Pemmaraju N, O’Brien S, Mulanovich VE, Estrov Z. Disseminated histoplasmosis as pseudo Richter’s transformation in a patient with chronic lymphocytic leukemia. Am J Hematol. 2015 Aug;90(8):752-3. doi: 10.1002/ajh.24029. PMID: 25850565
Baraban EG, Hu S, Hui P, Podoltsev N, Cooper D, Xu ML. Tissue based chimerism analysis enhances detection of donor derived neoplasm in allogeneic stem cell transplant patients. Bone Marrow Transplant. 2017 Apr;52(4):634-637. doi: 10.1038/bmt.2016.332. PMID: 27991892
Jain P, Milgrom SA, Patel KP, Nastoupil L, Fayad L, Wang M, Pinnix CC, Dabaja BS, Smith GL, Yu J, Hu S, Bueso-Ramos CE, Kanagal-Shamanna R, Medeiros LJ, Oki Y, Fowler N. Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma. Br J Haematol. 2017 Aug;178(3):403-412. doi: 10.1111/bjh.14672. PMID: 28382648
Fang L, Chen H, Tang Z, Kalhor N, Liu CH, Yao H, Hu S, Lin P, Zhao J, Luthra R, Singh RR, Routbort MJ, Hong D, Medeiros LJ, Lu X. MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer. Oncotarget 2018 Feb 7;9(16):12959-12970. doi: 10.18632/oncotarget.24430. PMID: 29560123
Boddu PC, Wang S, Pemmaraju N, Tang Z, Hu S, Li S, Xu J, Medeiros LJ, Tang G. 8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms. Leuk Res. 2018 Mar;66:73-78. doi: 10.1016/j.leukres.2018.01.013. PMID: 29407586
Chamoun K, Loghavi S, Pemmaraju N, Konopleva M, Kroll M, Nguyen-Cao M, Hornbaker M, DiNardo CD, Kadia T, Jorgensen J, Andreeff M, Hu S, Benton CB. Early detection of transformation to BPDCN in a patient with MDS. Exp Hematol Oncol 2018 Oct 6;7:26. doi: 10.1186/s40164-018-0117-6. eCollection 2018. PMID: 30323983
Tang Z, Li Y, Wang W, Yin CC, Tang G, Aung PP, Hu S, Lu X, Toruner GA, Medeiros LJ, Khoury JD. Genomic alterations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events. Leuk Res 2018 Oct; 73: 86-94. doi: 10.1016/j.leukres.2018.09.006. PMID: 30248580
Li K, Xu W, Lu K, Wen Y, Xin T, Shen Y, Lv X, Hu S, Jin R, Wu X. CSFR1 inhibition disrupts the dialogue between leukemia cells and macrophages and delays leukemia progression. J Cell Mol Med 2020 Oct 10;24(22):13115-28. doi: 10.1111/jcmm.15916. PMID: 33037771.
Fang H, Chuang HH, Strati P, Hu S, Shuai W, Medeiros LJ, Wang W. Post chemotherapy histiocyte-rich pseudotumor mimicking residual lymphoma: a report of 11 cases correlating clinicopathologic and radiologic findings. Am J Surg Pathol. 2020 Aug 5. doi: 10.1097/PAS.0000000000001547. PMID: 32769427. Online ahead of print.
Yin W, Cheng J, Tang Z, Toruner G, Hu S, Guo M, Robinson M, Medeiros LJ, Tang G. MET amplification (MET/CEP7 ratio >1.8) is an independent poor prognostic marker in patients with treatment-naïve non-small cell cancer. Clin Lung Cancer. 2021 Jul;22(4):e512-e518. doi: 10.1016/j.cllc.2020.11.002. PMID: 33288441.
Yin W, Liu W, Guo M, Tang Z, Toruner G, Robinson M, Cheng J, Hu S, Medeiros LJ, Tang G. Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients’ outcome. Exp Mol Pathol. 2021 Feb;118:104572. doi: 10.1016/j.yexmp.2020.104572. PMID: 33189723.
Ricks ET, Hu S, Hu Z. Cytokeratin-positive follicular dendritic cell sarcoma: a mimic of carcinoma. eJHaema. 2022 Feb;3(1):254-255. http://dx.doi.org/10.1002/jha2.344. PMID: 35846219.